Max Healthcare Institute Limited (BOM:543220)
1,022.00
-7.95 (-0.77%)
At close: Nov 18, 2026
Max Healthcare Institute Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Max Healthcare Institute stock has a consensus rating of "Buy" and an average price target of ₹1,105. The average 1-year stock price forecast is 8.11% higher than the current stock price, while the lowest is ₹825.00 (-19.28%) and the highest is ₹1,300 (+27.20%).
Price Target: ₹1,105 (+8.11%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Max Healthcare Institute stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 13 | 12 | 13 | 15 |
| Buy | 7 | 8 | 8 | 8 | 8 | 7 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 3 | 3 | 3 | 3 | 3 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 26 | 27 | 28 | 27 | 28 | 28 |
Financial Forecast
Revenue This Year
118.38B
from 83.73B
Increased by 41.37%
Revenue Next Year
140.62B
from 118.38B
Increased by 18.78%
EPS This Year
18.46
from 15.18
Increased by 21.54%
EPS Next Year
22.92
from 18.46
Increased by 24.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.